Clearside Biomedical's revenue meets expectations, while profits exceed forecasts.

According to the Clearside Biomedical (NASDAQ: CLSD) report, the earnings per share for the first quarter came in at -$0.100, aligning with analysts' expectations of -$0.100. The reported earnings for this quarter were determined to be $306K, while analyst expectations were set at $130.14K.

Clearside Biomedical's stock closed the day at $1.03, reflecting an impressive 8,420% increase over the past three months. However, the stock has experienced a decline of 32.680% over the last 12 months. In the past 90 days, Clearside Biomedical has seen four positive earnings per share and one negative. Explore how Clearside Biomedical's stock price reacted to previous earnings reports. According to InvestingPro, the company holds a "Very Good Performance" financial health score. Review the latest earnings reports and comprehensive financial information on Clearside Biomedical here. Stay updated on all developments regarding balance sheets by visiting the Investing.com Earnings Calendar.